|
| ||
|
|
Nootropics Archive / Nootropic Plants / Herbs / Ginkgo Biloba
Ginkgo BilobaFrom: spedge@csd4.csd.uwm.edu (Mary Mirtens) Newsgroups: alt.drugs Subject: Re: Gingko Biloba Date: 29 Oct 1993 01:54:58 GMT Message-ID: <2apt5iINNfac@uwm.edu>
From article
From Smart Drugs and Nutrients:
GINKGO BILOBA: A Nootropic Herb?
Ginkgo biloba is the oldest species of tree known. Extracts from the leaves of the
ginkgo biloba tree have been used by Chinese medicine for thousands of years.
European physicians write over 1.2 million prescriptions per month for it. Ginkgo biloba is
used to improve cerebral circulation, mental alertness, and overall brain functioning.
More than 34 human studies on ginkgo have been published since 1975, show ing
that ginkgo works by increasing blood flow throughout the body and brain. Ginkgo
increases the productions of adenosine triphosphate (ATP, the universal energy
molecule). It also improves the brain's ability to metabolize glucose, prevents platelet
aggregation inside arterial walls by keeping them flexible, improves the transmission of
nerve signals, and acts as a powerful antioxidant.
Ginkgo biloba leaf is effective for people with symptoms of reduced blood flow to the
brain and extremities. It has been shown to be helpful with many of the complaints of
the elderly such as: memory loss, slow thinking and reasoning, depression, dizziness,
ringing in the ears, headaches, and senile macular degeneration (a major cause of
blindness).
One study even shows significant improvement in people who have both Parkinson's
and Alzheimer's disease. In this study 25 people w/ Parkinson's disease and signs
of Alzheimer's disease were given ginkgo extract daily for one year. They were tested
with standard tests, clinical evaluations, and a new computerized EEG. The scores
improved significantly.
CITE: Funfgeld, E.W. "A natural and broad spectrum nootropic substance treatment of
SDAT - the gingko biloba extract". from Progress in Clinical and Biological Research,
1989, 317 (pp 1247-1260)
One study does not prove that Gingko biloba is efficacious in the treatment of these
diseases. However, ginkgo is safe, inexpensive and easily obtain ed, and people with
Parkingsons and/or Alzheimer's might consider experimenting with it.
PRECAUTIONS: No negative effects have been reported in the literature even in very
large quantities.
DOSAGE: Most research has been done with a gingko biloba extract which contained
a 24% concentration of flavinoid extract. At this strength, the usual dosage is
120-160mg per day taken in three divided doses. However, many gingko products are
lower in potency, and may require dosages as high as 1000mg per day. Three to six
months is probably needed to evaluate the results.
Buy the books!
"Smart Drugs and Nutrients" by Ward Dean & John Morgenthaler (1990) ISBN#
0-9627418-9-2 ($12.95)
"Smart Drugs II" by Ward Dean / John Morgenthaler / Steven Wm. Fowkes (1993)
ISBN# 0-9627418-7-6 ($14.95)
SD2 covers totally different material than the first book: Deprenyl, Melatonin,
Milacemide, Nimodipine, Phosphatidylserine, Pregnenolone, Ondansetron and Zatosetron.
The first book has: Pyrrolidone types
(Piracetam, Oxiracetam), Hydergine, Vasopressin, Fipexide, Vinopocetine,
Acetyl-L-Carnitine, Centrophenoxine, Choline, AL721, DHEA, DMAE, Gerovital GH-3,
Ginkgo, Ginseng, Idebenone (CoQ10), Phenytoin (dilantin), Inderal, Vincamine, etc.
| |
|
This page was created at 11/6/98; 7:00:40 PM and was last built on 4/29/99; 3:33:27 PM. Thank you for visiting. chris@hyperreal.org | ||